documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
235 rows where docket_id = "FDA-2017-N-0763" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 3
agency_id 1
- FDA 235
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2017-N-0763-1452 | FDA | None FDA-2017-N-0763 | Letter from Antonio McGee to FDA DDM | Other | Letter(s) | 2019-02-22T05:00:00Z | 2019 | 2 | 2019-02-22T05:00:00Z | 2019-02-22T15:15:44Z | 0 | 0 | 0900006483a98e8d | ||
| FDA-2017-N-0763-0867 | FDA | None FDA-2017-N-0763 | Food Labeling: Health Claims; Soy Protein and Coronary Heart Disease; Extension of Comment Period | Proposed Rule | Extension of Comment Period | 2018-01-17T05:00:00Z | 2018 | 1 | 2018-01-17T05:00:00Z | 2018-03-20T03:59:59Z | 2023-08-08T01:02:42Z | 2018-00683 | 0 | 0 | 0900006482e18b55 |
| FDA-2017-N-0763-0568 | FDA | None FDA-2017-N-0763 | Request for Extension from Soyfoods Association of North America | Other | Request for Extension | 2018-01-02T05:00:00Z | 2018 | 1 | 2018-01-02T05:00:00Z | 2018-01-02T14:51:45Z | 0 | 0 | 0900006482d7f5ea | ||
| FDA-2017-N-0763-0067 | FDA | None FDA-2017-N-0763 | Reference_64 van Raaij_1982_Influence of diets containing containing casein, soy isolate, and soy concentrate | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:33:37Z | 0 | 0 | 0900006482c14082 | |||
| FDA-2017-N-0763-0074 | FDA | None FDA-2017-N-0763 | Reference_77 Kurowska_1997_Effects of substituting dietary soybean protein and oil for milk protein | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:39:24Z | 0 | 0 | 0900006482c142aa | |||
| FDA-2017-N-0763-0099 | FDA | None FDA-2017-N-0763 | Reference_92 Wu_2005_A controlled 2-mo dietary fat reduction and soy food supplementation study in postmenopausal women | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:46:28Z | 0 | 0 | 0900006482c143b2 | |||
| FDA-2017-N-0763-0098 | FDA | None FDA-2017-N-0763 | Reference_93 Steele_The effect on serum cholesterol levels of substituting milk with a soya beverage | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:46:27Z | 0 | 0 | 0900006482c143b3 | |||
| FDA-2017-N-0763-0110 | FDA | None FDA-2017-N-0763 | Reference_101 Swain_2002_Iron indexes and total antioxidant status in responses to soy protein intake in perimenopausal | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:48:31Z | 0 | 0 | 0900006482c143f3 | |||
| FDA-2017-N-0763-0125 | FDA | None FDA-2017-N-0763 | Reference_126 D'Amico_1992_Effect of vegetarian soy diet on hyperlipidaemia in nephrotic syndrome | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:55:27Z | 0 | 0 | 0900006482c14455 | |||
| FDA-2017-N-0763-0160 | FDA | None FDA-2017-N-0763 | Reference_151 Jenkins_2003_Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T17:00:38Z | 0 | 0 | 0900006482c144bb | |||
| FDA-2017-N-0763-0156 | FDA | None FDA-2017-N-0763 | Reference_155 Jones_2005_Effects of a diet high in plant sterols, vegetable proteins, and viscous fibers | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T17:00:37Z | 0 | 0 | 0900006482c144bf | |||
| FDA-2017-N-0763-0121 | FDA | None FDA-2017-N-0763 | Reference_110 Nilausen_1998_Variable lipemic response to dietary soy protein in healthy,normolipemic men | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:50:24Z | 0 | 0 | 0900006482c145ea | |||
| FDA-2017-N-0763-0120 | FDA | None FDA-2017-N-0763 | Reference_111 Nilausen_1999_Lipoprotein(a) and dietary proteins-casein lowers lipoprotein(a) concentrations | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:50:24Z | 0 | 0 | 0900006482c145eb | |||
| FDA-2017-N-0763-0145 | FDA | None FDA-2017-N-0763 | Reference_146 Zittermann-2004_Short-term effects of high soy. supplementation on sex hormones, bone markers | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:59:20Z | 0 | 0 | 0900006482c146ae | |||
| FDA-2017-N-0763-0153 | FDA | None FDA-2017-N-0763 | Reference_158_NHLBI_2003_Seventh Report of the Joint National Committee on Prevention | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T17:00:36Z | 0 | 0 | 0900006482c146b3 | |||
| FDA-2017-N-0763-0229 | FDA | None FDA-2017-N-0763 | Reference_222 Yang_2005_Longitudinal study of soy food intake and blood pressure among middle-aged and elderly Chinese | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T17:10:50Z | 0 | 0 | 0900006482c146db | |||
| FDA-2017-N-0763-0223 | FDA | None FDA-2017-N-0763 | Reference_228 The ATBC cancer prevention study group._1994_The effect of vitamin E and beta carotene on the incidence | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T17:10:48Z | 0 | 0 | 0900006482c146e1 | |||
| FDA-2017-N-0763-0037 | FDA | None FDA-2017-N-0763 | Reference_34 Wong_1995_Cholesterol synthesis and absorption by 2h2o and 18o-cholesterol | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:16:45Z | 0 | 0 | 0900006482c13ffb | |||
| FDA-2017-N-0763-0196 | FDA | None FDA-2017-N-0763 | Reference_195 Gardner_2001_The effect of soy protein with or without isoflavones relative to milk protein onplasma lipids | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T17:06:07Z | 0 | 0 | 0900006482c1493f | |||
| FDA-2017-N-0763-0194 | FDA | None FDA-2017-N-0763 | Reference_197 Chen_2006_Effect of soya protein on serum lipid profile and lipoprotein concentrations in patients | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T17:06:06Z | 0 | 0 | 0900006482c14941 | |||
| FDA-2017-N-0763-0203 | FDA | None FDA-2017-N-0763 | Reference_208 Jenkins_2000_Effect of soy-based breakfast cereal on blood lipids and oxidized low-density lipoprotein | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T17:07:44Z | 0 | 0 | 0900006482c14973 | |||
| FDA-2017-N-0763-0216 | FDA | None FDA-2017-N-0763 | Reference_215 Ho_2000_Intake of soy products is associated with better plasma lipid profiles | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T17:09:53Z | 0 | 0 | 0900006482c149be | |||
| FDA-2017-N-0763-0018 | FDA | None FDA-2017-N-0763 | Reference_13 USDA_2016_Soy Milk,USDA National Nutrient Database for Standard Reference, 28 | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:14:28Z | 0 | 0 | 0900006482c13fbf | |||
| FDA-2017-N-0763-0015 | FDA | None FDA-2017-N-0763 | Reference_16 IOM_DRIs for Water, Potassium, Sodium, Chloride, and Sulfate | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:14:28Z | 0 | 0 | 0900006482c13fc2 | |||
| FDA-2017-N-0763-0060 | FDA | None FDA-2017-N-0763 | Reference_51 Potter_1976_Greater bile acid excretion with soy bean than with cow milk in infants | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:22:34Z | 0 | 0 | 0900006482c1423d | |||
| FDA-2017-N-0763-0090 | FDA | None FDA-2017-N-0763 | Reference_81 Gaddi_1987_Hypercholesterolaemia treated by soybean protein diet | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:43:46Z | 0 | 0 | 0900006482c142ae | |||
| FDA-2017-N-0763-0109 | FDA | None FDA-2017-N-0763 | Reference_102 Sirtori_Soy milk with a high glycitein content does not reduce low-density lipoprotein | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:48:31Z | 0 | 0 | 0900006482c143f4 | |||
| FDA-2017-N-0763-0127 | FDA | None FDA-2017-N-0763 | Reference_124_Mercer_1987_Effects of human plasma lipids of substituting soybean protein isolate for milk protein | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:55:27Z | 0 | 0 | 0900006482c14453 | |||
| FDA-2017-N-0763-0137 | FDA | None FDA-2017-N-0763 | Reference_134 Ham _1993_Endocrinological response to soy protein and fiber in mildly hypercholesterolemic men | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:58:08Z | 0 | 0 | 0900006482c14476 | |||
| FDA-2017-N-0763-0136 | FDA | None FDA-2017-N-0763 | Reference_135 Roughead_2005_Controlled substitution of soy protein for meat protein-effects on calcium retention, bone | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:58:08Z | 0 | 0 | 0900006482c14477 | |||
| FDA-2017-N-0763-0162 | FDA | None FDA-2017-N-0763 | Reference_169 Jayagopal_2002_Beneficial effects of soy phytoestrogen intake in postmenopausal women | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T17:02:06Z | 0 | 0 | 0900006482c144eb | |||
| FDA-2017-N-0763-0151 | FDA | None FDA-2017-N-0763 | Reference_140 Liao_2007_Effectiveness of a soy-based compared with a traditional low-calorie diet on weight loss | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:59:21Z | 0 | 0 | 0900006482c146a6 | |||
| FDA-2017-N-0763-0146 | FDA | None FDA-2017-N-0763 | Reference_145_Vigna_2000_Plasma lipoproteins in soy-treated postmenopausal women-a double-blind, placebo-controlled trial | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:59:20Z | 0 | 0 | 0900006482c146ab | |||
| FDA-2017-N-0763-0166 | FDA | None FDA-2017-N-0763 | Reference_165 McVeigh_2006_Effect of soy protein varying in isoflavone content on serum lipids | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T17:02:07Z | 0 | 0 | 0900006482c146ba | |||
| FDA-2017-N-0763-0173 | FDA | None FDA-2017-N-0763 | Reference_178 Takatsuka_2000_Hypocholesterolemic effect of soymilk supplementation with usual diet in premenopausal | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T17:03:25Z | 0 | 0 | 0900006482c14919 | |||
| FDA-2017-N-0763-0011 | FDA | None FDA-2017-N-0763 | Reference Index | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:11:40Z | 0 | 0 | 0900006482c13ba7 | |||
| FDA-2017-N-0763-0005 | FDA | None FDA-2017-N-0763 | Reference_06 NRC_2011_Reference Manual on Scientific Evidence Third Edition | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:11:39Z | 0 | 0 | 0900006482c13f9a | |||
| FDA-2017-N-0763-0002 | FDA | None FDA-2017-N-0763 | 010 Reference_09 AHRQ_2002_Systems to Rate the Scientific Evidence - 2002 | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:11:37Z | 0 | 0 | 0900006482c13f9d | |||
| FDA-2017-N-0763-0012 | FDA | None FDA-2017-N-0763 | Reference_19 Tormala_2006_Serum cholesterol efflux potential in postmenopausal women treated with isolated isoflavones | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:14:27Z | 0 | 0 | 0900006482c13fc5 | |||
| FDA-2017-N-0763-0050 | FDA | None FDA-2017-N-0763 | Reference_41 Sirtori_1979_Clinical experience with the soybean protein diet in the treatment of hypercholesterolemia | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:19:11Z | 0 | 0 | 0900006482c1401d | |||
| FDA-2017-N-0763-0045 | FDA | None FDA-2017-N-0763 | Reference_46 Lovati_1987_Soybean protein diet increases low density lipoprotein receptor activity in mononuclear cells | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:19:10Z | 0 | 0 | 0900006482c14022 | |||
| FDA-2017-N-0763-0195 | FDA | None FDA-2017-N-0763 | Reference_196 Hori_2001_Soy protein hydrolyzate with bound phospholipids reduces serum cholesterol levels | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T17:06:06Z | 0 | 0 | 0900006482c14940 | |||
| FDA-2017-N-0763-0192 | FDA | None FDA-2017-N-0763 | Reference_199_West_2005_Effects of including soy protein in a blood cholesterol-lowering diet on markers | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T17:06:06Z | 0 | 0 | 0900006482c1496a | |||
| FDA-2017-N-0763-0219 | FDA | None FDA-2017-N-0763 | Reference_212 He_2005_Effect of soybean protein on blood pressure-a randomized, controlled trial | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T17:09:54Z | 0 | 0 | 0900006482c149bb | |||
| FDA-2017-N-0763-0054 | FDA | None FDA-2017-N-0763 | Reference_57_Vessby_1982_The effects on lipid and carbohydrate metabolism of replacing some animal protein by soy-protein | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:22:32Z | 0 | 0 | 0900006482c1407b | |||
| FDA-2017-N-0763-0070 | FDA | None FDA-2017-N-0763 | Reference_61 Bonanome_1988_Effect of dietary stearic acid on plasma cholesterol and lipoprotein levels | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:33:37Z | 0 | 0 | 0900006482c1407f | |||
| FDA-2017-N-0763-0069 | FDA | None FDA-2017-N-0763 | Reference_62 Tabibi_2010_Effects of soy consumption on serum lipids and apoproteins in peritoneal dialysis patients | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:33:37Z | 0 | 0 | 0900006482c14080 | |||
| FDA-2017-N-0763-0027 | FDA | None FDA-2017-N-0763 | Reference_24 Vega-Lopez_2005-Plasma antioxidant capacity in response to diets high in soy | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:15:41Z | 0 | 0 | 0900006482c14213 | |||
| FDA-2017-N-0763-0062 | FDA | None FDA-2017-N-0763 | Reference_69 Stephenson_2005_Effect of soy protein-rich diet on renal function in young adults | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:33:35Z | 0 | 0 | 0900006482c14287 | |||
| FDA-2017-N-0763-0100 | FDA | None FDA-2017-N-0763 | Reference_91 Anderson_2005_Weight loss and lipid changes with low-energy diets-comparator study | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:46:28Z | 0 | 0 | 0900006482c143b1 | |||
| FDA-2017-N-0763-0097 | FDA | None FDA-2017-N-0763 | Reference_94 Deibert_2004_Weight loss without losing muscle mass in pre-obese and obese subjects | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:46:27Z | 0 | 0 | 0900006482c143b4 | |||
| FDA-2017-N-0763-0177 | FDA | None FDA-2017-N-0763 | Reference_174 Mangano-2013-Soy proteins and isoflavones reduce interleukin-6 but not serum lipids in older women | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T17:03:26Z | 0 | 0 | 0900006482c144f0 | |||
| FDA-2017-N-0763-0132 | FDA | None FDA-2017-N-0763 | Reference_139 D'Amico_1991_Effect of dietary proteins and lipids in patients with membranous nephropathy | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:58:07Z | 0 | 0 | 0900006482c146a5 | |||
| FDA-2017-N-0763-0150 | FDA | None FDA-2017-N-0763 | Reference_141 Li_2005_Long-term efficacy of soy-based meal replacements vs and individualized diet plan in obese type | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:59:21Z | 0 | 0 | 0900006482c146a7 | |||
| FDA-2017-N-0763-0149 | FDA | None FDA-2017-N-0763 | Reference_142 Chiechi_2002_The effects of a soy rich diet on serum lipids-the menfis randomized trial | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:59:20Z | 0 | 0 | 0900006482c146a8 | |||
| FDA-2017-N-0763-0191 | FDA | None FDA-2017-N-0763 | Reference_180 Murkies_Dietary flour supplmentation decreases post-menopausal hot flushes | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T17:04:32Z | 0 | 0 | 0900006482c1491b | |||
| FDA-2017-N-0763-0183 | FDA | None FDA-2017-N-0763 | Reference_188 Hoie_2006_Ultra heat treatment destroys cholesterol-lowering effect of soy protein | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T17:04:30Z | 0 | 0 | 0900006482c1492f | |||
| FDA-2017-N-0763-0206 | FDA | None FDA-2017-N-0763 | Reference_205 Desroches_2004_Soy protein favorably affects LDL size independently of isoflavones in hypercholesterolemic | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T17:07:44Z | 0 | 0 | 0900006482c14970 | |||
| FDA-2017-N-0763-0204 | FDA | None FDA-2017-N-0763 | Reference_207 Gardner_2007_Effect of two types of soy milk and dairy milk on plasma lipids in hypercholesterolemic | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T17:07:44Z | 0 | 0 | 0900006482c14972 | |||
| FDA-2017-N-0763-0021 | FDA | None FDA-2017-N-0763 | Reference_10 IOM DRIs for Dietary Fats, Chapter 8 | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:14:28Z | 0 | 0 | 0900006482c13f9e | |||
| FDA-2017-N-0763-0013 | FDA | None FDA-2017-N-0763 | Reference_18 Siefker_2006_Safety and antioxidant effects of a modest soy protein intervention in hemodialysis patients | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:14:27Z | 0 | 0 | 0900006482c13fc4 | |||
| FDA-2017-N-0763-0080 | FDA | None FDA-2017-N-0763 | Reference_71 Thorp_2008_Soy food consumption does not lower LDL cholesterol in either equol or nonequol producers | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:39:25Z | 0 | 0 | 0900006482c14289 | |||
| FDA-2017-N-0763-0072 | FDA | None FDA-2017-N-0763 | Reference_79 Ashton_Effects of soy as tofu vs meat on lipoprotein concentrations | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:39:23Z | 0 | 0 | 0900006482c142ac | |||
| FDA-2017-N-0763-0089 | FDA | None FDA-2017-N-0763 | Reference_82 Duane_Effects of soybean protein and very low dietary cholesterol on serum lipids, biliary lipids | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:43:46Z | 0 | 0 | 0900006482c142af | |||
| FDA-2017-N-0763-0087 | FDA | None FDA-2017-N-0763 | Reference_84 Hermansen_2005_Effects of soy supplementation on blood lipids and arterial function in hypercholesterolaemic | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:43:46Z | 0 | 0 | 0900006482c142b1 | |||
| FDA-2017-N-0763-0108 | FDA | None FDA-2017-N-0763 | Reference_103 Sirtori_1985_Cholesterol-lowering and HDL-raising properties of lecithinated soy proteins in type II | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:48:31Z | 0 | 0 | 0900006482c143f5 | |||
| FDA-2017-N-0763-0123 | FDA | None FDA-2017-N-0763 | Reference_128 Soroka_ 1998_Comparison of a vegetable-based (soya) and an animal-based low-protein diet | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:55:26Z | 0 | 0 | 0900006482c14457 | |||
| FDA-2017-N-0763-0140 | FDA | None FDA-2017-N-0763 | Reference_131 Jenkins_2002_A dietary portfolio approach to cholesterol reduction-combined effects of plant sterols | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:58:09Z | 0 | 0 | 0900006482c14473 | |||
| FDA-2017-N-0763-0144 | FDA | None FDA-2017-N-0763 | Reference_147 Cicero_2002_Effects of a new soy_beta-sitosterol supplement on plasma lipids in moderately | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:59:19Z | 0 | 0 | 0900006482c144b7 | |||
| FDA-2017-N-0763-0164 | FDA | None FDA-2017-N-0763 | Reference_167 Teixeira_2004_Isolated soy protein consumption reduces urinary albumin excretion and improves the serum | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T17:02:07Z | 0 | 0 | 0900006482c144e9 | |||
| FDA-2017-N-0763-0175 | FDA | None FDA-2017-N-0763 | Reference_176 Bakhit_1994_Intake of 25 g of soybean protein with or without soybean fiber alters plasma lipids | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T17:03:25Z | 0 | 0 | 0900006482c144f2 | |||
| FDA-2017-N-0763-0105 | FDA | None FDA-2017-N-0763 | Reference_106 Carroll_1978_Hypocholesterolemic effect of substituting soybean protein for animal protein in the diet | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:48:30Z | 0 | 0 | 0900006482c145e6 | |||
| FDA-2017-N-0763-0103 | FDA | None FDA-2017-N-0763 | Reference_108 Sacks_1983_Lack of an effect of dairy protein (casein) and soy protein on plasma cholesterol | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:48:30Z | 0 | 0 | 0900006482c145e8 | |||
| FDA-2017-N-0763-0148 | FDA | None FDA-2017-N-0763 | Reference_143 Chiechi_2002_Efficacy of a soy rich diet in preventing postmenopausal osteoporosis | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:59:20Z | 0 | 0 | 0900006482c146a9 | |||
| FDA-2017-N-0763-0009 | FDA | None FDA-2017-N-0763 | Reference_02 Balk_2005_ Effects of soy on health Outcomes | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:11:40Z | 0 | 0 | 0900006482c13f96 | |||
| FDA-2017-N-0763-0187 | FDA | None FDA-2017-N-0763 | Reference_184 Greany_2004_Probiotic consumption does not enhance the cholesterol-lowering effect of soy in postmenopausal | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T17:04:31Z | 0 | 0 | 0900006482c1491f | |||
| FDA-2017-N-0763-0208 | FDA | None FDA-2017-N-0763 | Reference_203 Lichtenstein_2002_Lipoprotein response to diets high in soy or animal protein with and without isoflavones | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T17:07:45Z | 0 | 0 | 0900006482c1496e | |||
| FDA-2017-N-0763-0217 | FDA | None FDA-2017-N-0763 | 215 Reference_214 Chan_2007_Isoflavone intake in persons at high risk of cardiovascular events-implications for vascular | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T17:09:53Z | 0 | 0 | 0900006482c149bd | |||
| FDA-2017-N-0763-0046 | FDA | None FDA-2017-N-0763 | Reference_45 Gardner-Thorpe_2003_Dietary supplements of soya flour lowers serum testosterone concentrations | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:19:10Z | 0 | 0 | 0900006482c14021 | |||
| FDA-2017-N-0763-0022 | FDA | None FDA-2017-N-0763 | Reference_29 Gallagher_2004_The effect of soy protein isolate on bone metabolism | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:15:39Z | 0 | 0 | 0900006482c13ff6 | |||
| FDA-2017-N-0763-0038 | FDA | None FDA-2017-N-0763 | Reference_33 Merz-Demlow_2000_Soy isoflavones improve plasma lipids in normocholesterolemic | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:16:45Z | 0 | 0 | 0900006482c13ffa | |||
| FDA-2017-N-0763-0055 | FDA | None FDA-2017-N-0763 | Reference_56 Fumagalli_1982_Fecal cholesterol excretion studies in type II hypercholesterolemic patients | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:22:32Z | 0 | 0 | 0900006482c1407a | |||
| FDA-2017-N-0763-0061 | FDA | None FDA-2017-N-0763 | Reference_50 Borodin_2009_Effects of two-month consumption of 30 g a day of soy protein isolate or skimmed curd protein | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:22:34Z | 0 | 0 | 0900006482c14239 | |||
| FDA-2017-N-0763-0076 | FDA | None FDA-2017-N-0763 | Reference_75 Ridges_2001_Cholesterol lowering benefits of soy and linseed enriched foods | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:39:24Z | 0 | 0 | 0900006482c142a8 | |||
| FDA-2017-N-0763-0096 | FDA | None FDA-2017-N-0763 | Reference_95 Puska_2002_Soy in hypercholesterolaemia_ a double-blind, placebo-controlled trial | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:46:27Z | 0 | 0 | 0900006482c143ed | |||
| FDA-2017-N-0763-0094 | FDA | None FDA-2017-N-0763 | Reference_97 Allison_2003_A novel soy-based meal replacement formula for weight loss among obese individuals | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:46:26Z | 0 | 0 | 0900006482c143ef | |||
| FDA-2017-N-0763-0107 | FDA | None FDA-2017-N-0763 | Reference_104 Sirtori_1999_Double-blind study of the addition of high-protein soya milk v. cows' milk to the diet | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:48:31Z | 0 | 0 | 0900006482c143f6 | |||
| FDA-2017-N-0763-0122 | FDA | None FDA-2017-N-0763 | Reference_129 Shige_199_-Effects of soy protein isolate (SPI) and casein on the postprandial lipemia | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:55:26Z | 0 | 0 | 0900006482c14458 | |||
| FDA-2017-N-0763-0139 | FDA | None FDA-2017-N-0763 | Reference_132 Jenkins_2000_The effect on serum lipids and oxidized low-density lipoprotein of supplementing | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:58:09Z | 0 | 0 | 0900006482c14474 | |||
| FDA-2017-N-0763-0163 | FDA | None FDA-2017-N-0763 | Reference_168 Murray_2003_Soy protein isolate with isoflavones does not prevent estradiol-induced endometrial hyperplasia | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T17:02:06Z | 0 | 0 | 0900006482c144ea | |||
| FDA-2017-N-0763-0167 | FDA | None FDA-2017-N-0763 | Reference_164 Kohno_2006_Decreases in serum triacylglycerol and visceral fat mediated by dietary soybean | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T17:02:07Z | 0 | 0 | 0900006482c146b9 | |||
| FDA-2017-N-0763-0231 | FDA | None FDA-2017-N-0763 | Reference_220 Rosell_2004_Soy intake and blood cholesterol concentrations-a cross-sectional study | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T17:10:50Z | 0 | 0 | 0900006482c146d9 | |||
| FDA-2017-N-0763-0227 | FDA | None FDA-2017-N-0763 | Reference_224 Zhang_2003_Soy food consumption is associated with lower risk of coronary heart disease in Chinese | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T17:10:49Z | 0 | 0 | 0900006482c146dd | |||
| FDA-2017-N-0763-0068 | FDA | None FDA-2017-N-0763 | Reference_63 St-Onge_2007_Supplementation with soy-protein-rich foods does not enhance weight loss | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:33:37Z | 0 | 0 | 0900006482c14081 | |||
| FDA-2017-N-0763-0058 | FDA | None FDA-2017-N-0763 | Reference_53 Campbell_2006_Effects of soy or milk protein during a high-fat feeding challenge on oxidative stress | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:22:33Z | 0 | 0 | 0900006482c1423f | |||
| FDA-2017-N-0763-0064 | FDA | None FDA-2017-N-0763 | Reference_67 Pipe_2009_Soy protein reduces serum LDL cholesterol | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:33:36Z | 0 | 0 | 0900006482c14285 | |||
| FDA-2017-N-0763-0130 | FDA | None FDA-2017-N-0763 | Reference_121 Huff_1984_Turnover of very low-density lipoprotein-apoprotein b is increased by substitution | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:55:28Z | 0 | 0 | 0900006482c14450 | |||
| FDA-2017-N-0763-0126 | FDA | None FDA-2017-N-0763 | Reference_125_D'Amico_1992_Effect of dietary manipulation on the lipid abnormalities and urinary protein loss | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:55:27Z | 0 | 0 | 0900006482c14454 | |||
| FDA-2017-N-0763-0138 | FDA | None FDA-2017-N-0763 | Reference_133 Jenkins_2000_Effect of soy protein foods on low-denisty lipoprotein oxidation and ex vivo | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:58:09Z | 0 | 0 | 0900006482c14475 | |||
| FDA-2017-N-0763-0135 | FDA | None FDA-2017-N-0763 | Reference_136 Yamashita_1998_Arterial compliance, blood pressure, plasma leptin, and plasma lipids in women | Supporting & Related Material | Background Material | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T16:58:08Z | 0 | 0 | 0900006482c14478 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;